Home > Insider Trading > Filing (0001179110-13-010367)

Filing Details

Accession Number:: 0001179110-13-010367
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-06-13 20:17:38
Reporting Period:: 2013-06-11

Filing Date:: 2013-06-13
Accepted Time:: 2013-06-13 20:17:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1113481	Medicines Co	MDCO	Pharmaceutical Preparations (2834)	043324394

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1318459	Michael Paul Antinori	8 Sylvan Way Parsippany NJ 07054	Sr. Vp & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-06-11	50,690	$19.36	102,596	No	4	M	Direct
Common Stock	Disposition	2013-06-11	50,690	$33.29	51,906	No	4	S	Direct
Common Stock	Acquisiton	2013-06-11	9,283	$12.95	61,189	No	4	M	Direct
Common Stock	Disposition	2013-06-11	9,283	$33.29	51,906	No	4	S	Direct
Common Stock	Acquisiton	2013-06-11	50,000	$22.47	101,906	No	4	M	Direct
Common Stock	Disposition	2013-06-11	50,000	$33.28	51,906	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (Right-to-buy)	Disposition	2013-06-11	50,690	$0.00	50,690	$19.36
Common Stock	Option (Right-to-buy)	Disposition	2013-06-11	9,283	$0.00	9,283	$12.95
Common Stock	Option (Right-to-buy)	Disposition	2013-06-11	50,000	$0.00	50,000	$22.47

Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2018-02-15	No	4	M	Direct
2019-02-20	No	4	M	Direct
2016-08-29	No	4	M	Direct

Footnotes

The common stock sales reported on this line of the Form 4 were effected pursuant to a Rule 10b5-1 program adopted by Mr. Antinori on May 9, 2013.
As of June 11, 2013, the original grant (50,960 shares granted on February 15, 2008) was fully vested. After the exercise of the options reported hereby, all shares covered by this option have been exercised.
As of June 11, 2013, the original grant (9,283 shares granted on February 20, 2009) was fully vested. After the exercise of the options reported hereby, all shares covered by this option have been exercised.
As of June 11, 2013, the original grant (50,000 shares granted on August 29, 2006) was fully vested. After the exercise of the options reported hereby, all shares covered by this option have been exercised.
The range of prices for the transactions reported on this line is between $32.96 and $33.65 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full informaton regarding the number of shares sold at each separate price
The range of prices for the transactions reported on this line is between $32.99 and $33.68 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full informaton regarding the number of shares sold at each separate price.